Renin-angiotensin system inhibitors and mortality among diabetic patients with STEMI undergoing mechanical reperfusion during the COVID-19 pandemic
Journal
Diabetes epidemiology and management
Journal Volume
4
Pages
100022
Date Issued
2021
Author(s)
De Luca, Giuseppe
Nardin, Matteo
Algowhary, Magdy
Uguz, Berat
Oliveira, Dinaldo C
Ganyukov, Vladimir
Zimbakov, Zan
Cercek, Miha
Jensen, Lisette Okkels
Loh, Poay Huan
Calmac, Lucian
Roura Ferrer, Gerard
Quadros, Alexandre
Milewski, Marek
Scotto di Uccio, Fortunato
von Birgelen, Clemens
Versaci, Francesco
Ten Berg, Jurrien
Casella, Gianni
Lung, Aaron Wong Sung
Kala, Petr
Díez Gil, José Luis
Carrillo, Xavier
Dirksen, Maurits
Becerra-Munoz, Victor M
Lee, Michael Kang-Yin
Juzar, Dafsah Arifa
de Moura Joaquim, Rodrigo
Paladino, Roberto
Milicic, Davor
Davlouros, Periklis
Bakraceski, Nikola
Zilio, Filippo
Donazzan, Luca
Kraaijeveld, Adriaan
Galasso, Gennaro
Lux, Arpad
Marinucci, Lucia
Guiducci, Vincenzo
Menichelli, Maurizio
Scoccia, Alessandra
Yamac, Aylin Hatice
Mert, Kadir Ugur
Flores Rios, Xacobe
Kovarnik, Tomas
Kidawa, Michal
Moreu, Josè
Flavien, Vincent
Fabris, Enrico
Martínez-Luengas, Iñigo Lozano
Boccalatte, Marco
Bosa Ojeda, Francisco
Arellano-Serrano, Carlos
Caiazzo, Gianluca
Cirrincione, Giuseppe
Sanchis Forés, Juan
Vignali, Luigi
Pereira, Helder
Manzo, Stephane
Ordoñez, Santiago
Arat Özkan, Alev
Scheller, Bruno
Lehtola, Heidi
Teles, Rui
Mantis, Christos
Antti, Ylitalo
Brum Silveira, João António
Zoni, Rodrigo
Bessonov, Ivan
Savonitto, Stefano
Kochiadakis, George
Alexopulos, Dimitrios
Uribe, Carlos E
Kanakakis, John
Faurie, Benjamin
Gabrielli, Gabriele
Gutierrez Barrios, Alejandro
Bachini, Juan Pablo
Rocha, Alex
Tam, Frankie Chor-Cheung
Rodriguez, Alfredo
Lukito, Antonia Anna
Saint-Joy, Veauthyelau
Pessah, Gustavo
Tuccillo, Andrea
Cortese, Giuliana
Parodi, Guido
Bouraghda, Mohammed Abed
Kedhi, Elvin
Lamelas, Pablo
Suryapranata, Harry
Verdoia, Monica
Abstract
During the coronavirus disease 2019 (COVID-19) pandemic, concerns have been arisen on the use of renin-angiotensin system inhibitors (RASI) due to the potentially increased expression of Angiotensin-converting-enzyme (ACE)2 and patient's susceptibility to SARS-CoV2 infection. Diabetes mellitus have been recognized favoring the coronavirus infection with consequent increase mortality in COVID-19. No data have been so far reported in diabetic patients suffering from ST-elevation myocardial infarction (STEMI), a very high-risk population deserving of RASI treatment.
SDGs
Type
journal article